Article Details
Retrieved on: 2019-09-13 23:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Eidelman Virant Capital bought a new position in ImmuCell during the second quarter valued at approximately $91,000. <b>Vanguard Group</b> Inc. grew its ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here